Cardiovascular Burden and Adverse Events in Patients With Esophageal Cancer Treated With Chemoradiation for Curative Intent.

ABSTRACT:

Objectives

The aim of this study was to characterize the cardiovascular disease (CVD) profile and describe the incidence and characteristics of cardiovascular (CV) events in patients with esophageal cancer (EC) following chemoradiation and surgery.

Background

Underlying CVD is a concern in patients with EC receiving curative treatment with chemoradiation and surgery.

Methods

Consecutive patients with EC referred for curative treatment were enrolled. Clinical CVD status, ongoing CVD treatment, cardiac function, and physical performance were assessed before chemoradiation. During a 90-day follow-up period, all CV events were noted and classified after in-depth medical record review. CV events were defined by major adverse CV events (transient ischemic attack, imaging-ve

SUBMITTER: Sondergaard MMA 

PROVIDER: S-EPMC8702793 | biostudies-literature | 2021 Dec

REPOSITORIES: biostudies-literature